Stay updated with breaking news from Foresight Diagnostic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PhasED-Seq ctDNA detection enables accurate and predictive treatment response monitoring and clinical prognosis in patients with B-cell lymphoma.A...
/PRNewswire/ -- Foresight Diagnostics, a leader in minimal residual disease (MRD) detection technology, announced today that three studies utilizing their...
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the 16th International Conference on Malignant Lymphoma (ICML) on June 18-22, 2021.